Phenotypic variability of PINK1 expression: 12 Years' clinical follow-up of two Italian families-Reference-Cited by-同舟云学术

Phenotypic variability of PINK1 expression: 12 Years' clinical follow-up of two Italian families

Published:2014-08-27 Issue:12 Volume:29 Page:1561-1566
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Ricciardi Lucia¹,Petrucci Simona²³,Guidubaldi Arianna¹,Ialongo Tamara¹,Serra Laura⁴,Ferraris Alessandro²,Spanò Barbara⁴,Bozzali Marco⁴,Valente Enza Maria²⁵,Bentivoglio Anna Rita¹

Affiliation:

1. Institute of Neurology, Università Cattolica del Sacro Cuore; Rome Italy

2. IRCCS Casa Sollievo della Sofferenza; Mendel Laboratory; San Giovanni Rotondo Italy

3. Department of Experimental Medicine; Sapienza University; Rome Italy

4. Neuroimaging Laboratory; IRCCS Santa Lucia Foundation; Rome Italy

5. Department of Medicine and Surgery; University of Salerno; Salerno Italy

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference40 articles.

1. Hereditary early-onset Parkinson's disease caused by mutations in PINK1;Valente;Science,2004

2. Autosomal recessive parkinsonism;Bonifati;Parkinsonism Relat Disord,2012

3. PINK1 heterozygous rare variants: prevalence, significance and phenotypic spectrum;Marongiu;Hum Mutat,2008

4. Co-occurrence of affective and schizophrenia spectrum disorders with PINK1 mutations;Steinlechner;J Neurol Neurosurg Psychiatry,2007

5. Neuropsychiatric and cognitive features in autosomal-recessive early parkinsonism due to PINK1 mutations;Ephraty;Mov Disord,2007

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aging accelerates locomotor decline in PINK1 knockout rats in association with decreased nigral, but not striatal, dopamine and tyrosine hydroxylase expression;Experimental Neurology;2024-06

2. PINK1 knockout rats show premotor cognitive deficits measured through a complex maze;Frontiers in Neuroscience;2024-05-16

3. Aging hastens locomotor decline in PINK1 knockout rats in association with decreased nigral, but not striatal, dopamine and tyrosine hydroxylase expression;2024-02-04

4. Cell Therapy for Parkinson’s Disease;Pharmaceutics;2023-11-22

5. Kanamycin treatment in the pre-symptomatic stage of a Drosophila PD model prevents the onset of non-motor alterations;Neuropharmacology;2023-09